The British
Pharmacopoeia 2017
Author:The British
Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products
Regulatory Agency (MHRA)
Publisher: TSO (The
Stationery Office)
The British Pharmacopoeia
(BP) 2017 supersedes the BP 2016 and becomes legally effective on 1 January
2017. This edition incorporates new BP and European Pharmacopoeia monographs
and a significant number of revised monographs. Also included is new
information for unlicensed medicines and DNA barcoding.
Updated annually, the BP is the only comprehensive
collection of authoritative official standards for UK pharmaceutical substances
and medicinal products.
The BP 2017 includes almost 4,000 monographs which are
legally enforced by the Human Medicines Regulations 2012. Where a
pharmacopoeial monograph exists, medicinal products sold or supplied in the UK
must comply with the relevant monograph. All monographs and requirements of the
European Pharmacopoeia are also reproduced in the BP.
New for 2017
·
29 new BP monographs
·
234 amended monographs
·
Four new formulated preparation monographs for biological
medicines
·
Two new monographs for unlicensed formulations
·
A new Supplementary Chapter on DNA barcoding
·
A new Supplementary Chapter on the aseptic Preparation of
Unlicensed Medicines
·
All European Pharmacopoeia monographs integrated (8th
Edition as amended by Supplements 8.1 to 8.8)
·
Three in-year website and offline download updates to
harmonise with the European Pharmacopoeia 9th Edition (9.0) and Supplements 9.1
and 9.2
The British Pharmacopoeia 2017 package consists of
·
A six-volume printed edition, including the BP (Veterinary)
2017
·
A single-user online licence*
·
A single-user download for offline use*
*These single-user licences are granted solely to the
designated holder of the product within an organisation. Multi-user licences
are available.
No comments:
Post a Comment